• (-)-Arctigenin as a MEK1 Inhibitor: Protocols and Solutions

  2026-04-30

  (-)-Arctigenin is a high-purity MEK1 inhibitor with proven anti-inflammatory and antiviral actions. This guide delivers workflow-optimized protocols, troubleshooting strategies, and translational insights for leveraging Arctigenin in cell signaling and disease models.

• Gamma-linolenic Acid: Applied Workflows for Inflammation Res

  2026-04-30

  Gamma-linolenic acid (GLA) stands apart as a dual-action modulator: it is both a weak leukotriene B4 antagonist and a DNA-safe agent for inflammation and cell-death research. This guide translates GLA’s molecular profile into actionable, reproducible workflows—backed by peer-reviewed data and real-world troubleshooting insights.

• Pharmacokinetic Variability of CSBTA in MASH: Mechanisms & I

  2026-04-29

  This study elucidates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. The findings reveal that disease state and repeated dosing significantly affect systemic and hepatic exposure of CSBTA components by modulating CYP450 enzymes and transporters, informing rational dosage strategies in MASH therapy.

• Novel AR Antagonists Bypass Resistance in Prostate Cancer Mo

  2026-04-29

  This study introduces benzo[b]oxepine-4-carboxamide derivatives as androgen receptor (AR) antagonists that act via the AR dimer interface pocket, rather than the traditional ligand-binding pocket. The approach achieves potent antagonism and degradation of wild-type and drug-resistant AR variants, offering new strategies for overcoming therapeutic resistance in prostate cancer.

• Prochlorperazine: Deep Mechanistic Insights for Oncology and

  2026-04-28

  Explore Prochlorperazine’s multifaceted role as a dopamine D2 receptor antagonist in oncology and antiviral research. This article offers advanced mechanistic analysis, practical protocol guidance, and unique cross-domain insights not found in prior reviews.

• Demethyleneberberine Inhibits NF-κB/MAPK in Autoimmune Hepat

  2026-04-28

  This study demonstrates that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, attenuates concanavalin A-induced autoimmune hepatitis in mice by suppressing NF-κB and MAPK signaling pathways. The findings highlight DMB's potential as a multi-pathway anti-inflammatory compound with translational relevance for autoimmune and inflammatory liver research.

• Sulfamonomethoxine: Protocols, Environmental Impact & Innova

  2026-04-27

  Sulfamonomethoxine (SMM) is redefining standards in veterinary, aquaculture, and environmental research with its robust antibacterial action and unique biotransformation routes. This article delivers actionable protocols, troubleshooting insights, and the latest findings on SMM’s fate and safety, empowering researchers to balance efficacy and stewardship.

• EGTA in Translational Research: Precision in Calcium Modulat

  2026-04-27

  This article explores EGTA (egtaizic acid) as a selective calcium chelator, bridging mechanistic insights with actionable strategies for translational researchers. Unpacking the latest neurophysiological evidence and competitive perspectives, it guides the rational deployment of EGTA in neurodegenerative disease models, apoptosis assays, and vascular inflammation studies—integrating protocol parameters, cross-domain considerations, and a visionary outlook for the next decade of calcium signaling research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-04-26

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is strictly recommended for in vitro applications and should not be used in in vivo or clinical research due to the lack of supporting data.

• TRIM21 Promotes ERK1/2-Driven Proliferation and Resistance i

  2026-04-25

  This study uncovers TRIM21 as a key oncogenic driver in pituitary adenomas, facilitating cell proliferation and resistance to dopamine agonists by modulating ERK1/2 ubiquitination and phosphorylation. The identification of Quisinostat as an effective agent for downregulating TRIM21 expression presents a potential therapeutic avenue for drug-resistant pituitary tumors.

• Berberrubine Chloride: Advanced Workflows for Cancer & Metab

  2026-04-24

  Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride) unlocks multiplexed bioactivity for translational cancer and metabolic research. This guide details experimental workflows, optimization tactics, and troubleshooting tips to maximize the impact of this selective, DMSO-soluble alkaloid.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-04-24

  Dimethyloxalylglycine (DMOG) provides a controlled, reproducible method for stabilizing hypoxia-inducible factors in cell and animal models—supporting hypoxia, inflammation, and infection research. It is not appropriate for diagnostic or clinical applications and should be used strictly according to laboratory protocols.

• Baicalein (5,6,7-Trihydroxy-2-phenylchromen-4-one): Mechanis

  2026-04-23

  Baicalein is a flavonoid compound known for potent inhibition of arachidonic acid metabolism and anti-proliferative effects on cancer cells. It is widely utilized in apoptosis and inflammation pathway research, with high solubility in DMSO and ethanol. Strict storage (-20°C) and handling protocols ensure optimal stability for laboratory applications.

• Prochlorperazine (SKU A8508): Reliable Research Applications

  2026-04-23

  This article provides scenario-driven guidance for biomedical researchers utilizing Prochlorperazine (SKU A8508) in cell viability, cytotoxicity, and melanoma studies. Evidence-based protocol parameters, real-world troubleshooting, and vendor selection considerations are explored, supporting reproducible outcomes in cancer and antiviral research workflows.

• Hydroxytyrosol: Precision Redox Modulation in Cardiovascular

  2026-04-22

  Explore the advanced redox-modulating properties of Hydroxytyrosol, a phenolic compound central to cardiovascular health research. This article delivers a unique, mechanistic perspective and practical assay guidance, distinguishing it from standard protocol or workflow content.

15388 records 1/1026 page Next 12345 下5页 Last page